22:45 , Nov 17, 2016 |  BC Week In Review  |  Company News

EnBiotix, AMP deal

EnBiotix acquired AMP Therapeutics for an undisclosed sum and formed subsidiary EnBiotix GmbH, which EnBiotix said will facilitate partnering and fundraising in Europe. AMP was developing a portfolio of antimicrobial peptides, which EnBiotix plans to...